- Home
- PSNL vs DCBO Comparison
PSNL vs DCBO Comparison
Compare PSNL & DCBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PSNL | DCBO |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.1M | 723.3M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PSNL | DCBO |
|---|---|---|
| Price | $9.19 | $21.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $10.71 | ★ $35.57 |
| AVG Volume (30 Days) | ★ 1.4M | 83.3K |
| Earning Date | 11-04-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.42 |
| EPS | N/A | ★ 0.74 |
| Revenue | $69,103,000.00 | ★ $236,691,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | $20.33 | $7.43 |
| P/E Ratio | ★ N/A | $29.94 |
| Revenue Growth | N/A | ★ 13.16 |
| 52 Week Low | $2.83 | $20.20 |
| 52 Week High | $11.40 | $50.80 |
Technical Indicators
Market Signals| Indicator | PSNL | DCBO |
|---|---|---|
| Relative Strength Index (RSI) | 49.56 | 44.95 |
| Support Level | $9.34 | $21.38 |
| Resistance Level | $9.85 | $22.61 |
| Average True Range (ATR) | 0.78 | 0.57 |
| MACD | -0.12 | 0.32 |
| Stochastic Oscillator | 31.13 | 73.79 |
Price Performance
Historical ComparisonAbout PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About DCBO Docebo Inc.
Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.